Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

50.7K
Overview
50.7K
Cancer Vaccines01:30

Cancer Vaccines

861
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
861
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

783
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
783
Cross-reactivity00:42

Cross-reactivity

32.6K
Overview
32.6K
Immunological Memory01:23

Immunological Memory

14.6K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
14.6K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

2.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transfusion-Associated Graft-Versus-Host Disease Risk and Transfusion Requirements After Cladribine in Multiple Sclerosis: Time to Revise Irradiation Policy?

European journal of neurology·2026
Same author

UK consensus on pregnancy in multiple sclerosis: An update to 'Association of British Neurologists' guidance.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial.

Health technology assessment (Winchester, England)·2026
Same author

Factors associated with severe COVID-19 in immunocompromised subgroups in England from 2020 to 2024: an OpenSAFELY cohort study.

EBioMedicine·2026
Same author

The Multiple Sclerosis Severity Allele rs10191329<sup>A</sup> and Cognitive Function: A UK Biobank Study.

Annals of clinical and translational neurology·2026
Same author

Progression to Wheelchair in Secondary Progressive Multiple Sclerosis and Impact of Siponimod: Post Hoc Analyses From the EXPAND Study.

European journal of neurology·2026

Related Experiment Video

Updated: Dec 15, 2025

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.6K

Protecting people with multiple sclerosis through vaccination.

Saúl Reyes1,2, Mary Ramsay3, Shamez Ladhani3

  • 1Neuroscience and Trauma, Blizard Institute of Cell and Molecular Science, London, UK saul.reyes@nhs.net.

Practical Neurology
|July 8, 2020
PubMed
Summary
This summary is machine-generated.

Vaccination is crucial for protecting individuals with multiple sclerosis (MS) from infections. This review addresses concerns about vaccine safety and efficacy in MS patients, offering guidance for clinicians and patients.

Keywords:
BiochemistryCSFEpilepsyImmunologyInfectious DiseasesLambert-Eaton SyndromeMagnetic StimulationMriMultiple SclerosisMyelopathyNeuroimmunologyParaproteinaemiaPostmortemStiff Man SyndromeTrigeminal NeuralgiaTuberculosis

More Related Videos

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

1.2K
Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

2.0K

Related Experiment Videos

Last Updated: Dec 15, 2025

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.6K
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

1.2K
Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

2.0K

Area of Science:

  • Neurology
  • Immunology
  • Public Health

Background:

  • Multiple sclerosis (MS) patients face increased risks of severe outcomes from vaccine-preventable infections.
  • Misconceptions regarding vaccine-induced exacerbation of MS and interactions with disease-modifying therapies (DMTs) hinder vaccination uptake.
  • Proactive vaccination strategies are essential for improving health outcomes in the MS population.

Purpose of the Study:

  • To review current literature on vaccination in adults with multiple sclerosis.
  • To provide evidence-based recommendations on vaccine safety and efficacy for MS patients.
  • To guide clinicians and patients in addressing vaccination reluctance and optimizing immunization schedules.

Main Methods:

  • Comprehensive literature review of studies on vaccines and multiple sclerosis.
  • Analysis of data concerning vaccine safety in patients on disease-modifying therapies (DMTs).
  • Synthesis of recommendations for vaccination strategies, including during pregnancy and for travelers.

Main Results:

  • Vaccination is a safe and effective method to prevent infections in individuals with MS.
  • Concerns about vaccines exacerbating MS or interacting negatively with DMTs are largely unfounded.
  • Specific guidance is provided for various vaccination scenarios in MS patients, including those on specific DMTs.

Conclusions:

  • Vaccination is a critical preventive health measure for people with MS.
  • Addressing patient and clinician concerns with clear, evidence-based information is vital.
  • Optimized vaccination protocols can significantly reduce morbidity and mortality from infections in MS patients.